Feasibility of HPV Testing With Mail-delivered Sample Collection Kits

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age35+
SponsorUniversity of California, San Francisco

About this trial

People living with human immunodeficiency virus (PLWH) have an estimated 1.6-6.0 times increased risk of developing oropharyngeal cancer (OPC) compared with individuals in the general population. 70% of OPCs are caused by human papillomavirus (HPV), and PLWH also have an increased prevalence of oral HPV infection. Disparities by race/ethnicity also include a later stage of diagnosis and less frequent cancer-directed treatment for members of ethnic minority groups. There is little known regarding the racial/ethnic differences in oral HPV infection, persistence of oral HPV infection, or progression of oral HPV infection to OPC among PLWH. This is an observational, prospective cohort study to investigate the feasibility of alternative sample collection methods for HPV testing among PLWH.

Eligibility criteria

Qualifiers

Over 35 years of age

Member of a sexual or gender group considered sexual minority men (men who have sex with men, trans-women)

Person living with HIV

Willing and able to receive a package through United States (US) postal service

Disqualifiers

Does not meet the above criteria

Trial design

Treatments tested in this trial

  • Mail-based Saliva Sample Kit
  • Study-related Surveys

Treatment groups

135 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

National Institute of Dental and Craniofacial Research (NIDCR)

Collaborator